Imagen de Portada

Adverse drug reactions in internal medicine units at a university hospital: A descriptive pilot study

Fuente: Redalyc

Guardado en:

Detalles Bibliográficos
Autor principal:	LUIS CARLOS LÓPEZ
Formato:	Artículo científico
Lenguaje:	en
Publicado:	Universidad del Valle 2010
Materias:	Medicina hospitalized patients Adverse drug reactions pharmacological surveillance
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

What drugs are most effective for reducing agitation in hospital patients?
por: Tripdatabase
Publicado: (2026)

Pruebas modificadas de degranulación de basófilos y factor de inhibición de migración de leucocitos en alergia a fármacos. Estudio de 2009 a 2014
por: María de Lourdes Irigoyen-Coria
Publicado: (2016)

The PharmWatch programme: challenges to engaging the community pharmacists in Jamaica
por: Maxine GOSSELL-WILLIAMS
Publicado: (2008)

Characterization of adverse events during the treatment with heberprot-P in four cuban provinces.
por: Alina R. Alvarez Crespol
Publicado: (2015)

In a patient with a prior history of Stevens-Johnson syndrome (SJS) induced by sertraline, what is the risk of developing SJS with venlafaxine?
por: Tripdatabase
Publicado: (2026)

Detecting adverse drug events during the hospital stay
por: C. Berga Culleré
Publicado: (2009)

What is the prevalence of allergic reactions to methylphenidate?
por: Tripdatabase
Publicado: (2026)

Clinical pharmacology of cannabidiol in refractory epilepsy
por: Paula Schaiquevich
Publicado: (2020)

PREVENTIVE STRATEGIES OF ADVERSE EVENTS WITH POTENTIALLY DANGEROUS MEDICATIONS
por: Flavia Giron Camerini
Publicado: (2013)

What are the signs and symptoms of methenamine-induced hypersensitivity reactions?
por: Tripdatabase
Publicado: (2026)

Relationship between anticholinergic load and selfperceived health in a population aged 44 years or older
por: Eliz Cassieli Pereira Pinto
Publicado: (2023)

Incidence and risk factors of major toxicity associated to first-line antituberculosis drugs for latent and active tuberculosis during a period of 10 years
por: Ana Tavares e Castro
Publicado: (2015)

D3.1 Report on the member states survey on hospital surveillance and description of piloting plans
por: The National Institute for Health and Welfare, et al.
Publicado: (2025)

WP3 D3.1 Report on the member states survey on hospital surveillance and description of piloting plans | UNITED4Surveillance
por: The National Institute for Health and Welfare, et al.
Publicado: (2025)

How do I transition a patient from fedratinib to momelotinib?
por: Tripdatabase
Publicado: (2026)

Different types of cancer in children and their treatments in a Mexican pediatric hospital
por: David Calderón-Guzmán
Publicado: (2009)

Adverse drug reactions in Colombian patients, 2007-2013: Analysis of population databases
por: Jorge Enrique Machado-Alba
Publicado: (2016)

What is the recommended dose adjustment for doxorubicin in patients on RCHOP who are stable on fluoxetine?
por: Tripdatabase
Publicado: (2026)

Pulmonary nocardiosis treated with tedizolid
por: Víctor Giménez-Arufe
Publicado: (2019)

How well are the effects of liraglutide on cardiovascular events for patients without diabetes documented?
por: Tripdatabase
Publicado: (2026)

Characteristics of patients hospitalized at an intensive care unit due to drug abuse
por: Flávia Antunes
Publicado: (2013)

Safety of SGLT2 inhibitors in very elderly diabetic type 2 patients in real life
por: Ramón Baeza-Trinidad
Publicado: (2023)

Intelligent Pharmacy
Publicado: (2025)

Patologías dermatológicas de origen nutricional en los pequeños animales: una revisión
por: María S. Gonzalez-Dominguez
Publicado: (2016)

Can amisulpride cause bruising?
por: Tripdatabase
Publicado: (2026)

Real-World Safety Profile of Xanomeline-Trospium (Cobenfy), the First Muscarinic Agonist Antipsychotic: A Disproportionality Analysis of the FDA Adverse Event Reporting System
por: Farquhar, Hayden
Publicado: (2026)

Protocol for the development and validation of a trigger tool for antiretroviral ADE detection among adult HIV/AIDS patients: A short communication
por: Amaka Yves-Ann Ezeuko, et al.
Publicado: (2024)

Future Pharmacology
Publicado: (2022)

Nuevas fronteras en la farmacoterapia de la hipertensión arterial
por: Evelyn Lissette Yong Chimbo
Publicado: (2019)

The effect of mental work load on personals’ sleep quality and reaction time, on the hospitals’ laboratories of Isfahan
por: Ehsanollah habibi
Publicado: (2018)

Pharmacological Research
Publicado: (2023)

Interstitial Lung Disease Associated with Chronic Nitrofurantoin Use
por: Erick Jafet González Roblero, et al.
Publicado: (2025)

What is the recommended management approach for a patient diagnosed with drug-induced uveitis, including specific therapies and cessation of the offending drug?
por: Tripdatabase
Publicado: (2025)

Have there been quality improvement projects to review drug libraries in drug error reduction software on intravenous infusion pumps?
por: Tripdatabase
Publicado: (2026)

BMC Pharmacology and Toxicology
Publicado: (2013)

Clinical Pharmacology: Advances and Applications
Publicado: (2010)

How does trigger-based surveillance affect patient safety outcomes in neonatal intensive care units?
por: Tripdatabase
Publicado: (2025)

A prospective microbial surveillance project at a major Italian Hospital. Epidemiological perspectives, and in vitro susceptibility rates
por: Roberto Manfredi
Publicado: (2009)

Drug-drug interactions in hospitalized older adults with acute coronary syndrome – a real-world study in Brazil
por: Tiago Aparecido Maschio de Lima
Publicado: (2024)

ADMET and DMPK
Publicado: (2017)